The Efficacy and Safety of Trapezius MSAT on Acute Whiplash Injury
1 other identifier
interventional
100
1 country
2
Brief Summary
This study is a double blind, randomized controlled trail. condition/disease: acute neck pain treatment/intervention: motion style acupuncture treatment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2019
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 3, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 7, 2019
CompletedFirst Submitted
Initial submission to the registry
October 1, 2019
CompletedFirst Posted
Study publicly available on registry
October 3, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2019
CompletedMarch 27, 2020
March 1, 2020
2 months
October 1, 2019
March 25, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Numeric Rating Scale(NRS) of neck pain
The extent of posterior neck pain and discomfort was assessed using NRS. NRS is a pain scale in which the patient indicates their subjective pain as a whole number from 0 to 10. The participant is asked to report their posterior neck pain and discomfort using NRS, where 0 indicates 'no pain or discomfort' and 10 indicates 'the most severe pain and discomfort imaginable'.
day 5
Secondary Outcomes (9)
Visual Analogue Scale (VAS) of neck pain
day 5
Visual Analogue Scale (VAS) of arm pain
day 5
Numeric Rating Scale(NRS) of arm pain
day 5
Physical examination (Cervical range of motion)
day 5
Neck Disability Index (NDI)
day 5
- +4 more secondary outcomes
Study Arms (2)
trapezius motion style acupuncture treatment
EXPERIMENTALThe MSAT group recieved 3 sessions of MSAT; on second, third, fourth day after hospitalization. A trained doctor of Korean medicine with at least 3 years of clinical experience conducted the MSAT. The MSAT group were also treated with other Korean medical treatment everyday: acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.
Korean medical treatment
ACTIVE COMPARATORThe control group were received Korean medical treatment everyday after hospitalization: acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.
Interventions
Motion Style Acupuncture Treatment(MSAT) is a therapeutic technique using acupuncture needle created in Jaseng Hospital. This treatment involves patients with musculoskeletal pain to move the part of their body actively during acupuncture treatment under physicians' observation
acupuncture treatment, chuna, pharmacoacupuncture, Korean herbal medicine
Eligibility Criteria
You may qualify if:
- Patients who needs hospitalization due to acute whiplash injury that occurred within 7 days after traffic accident
- Patients with NRS ≥ 5 for posterior neck pain
- Patients aged 19-70 years on the date they sign the consent form
- Patients who provide consent to participate in the trial and return the informed consent form
You may not qualify if:
- Patients with a specific serious disease that may cause spinal pain: malignancy, spondylitis, inflammatory spondylitis, etc.
- Patients with progressive neurological deficits or with severe neurological symptoms
- Patients who have had surgery or procedures within the last three weeks
- The cause of pain is due to soft tissue disease, not the spine: tumors, fibromyalgia, rheumatoid arthritis, gout, etc.
- Patients with other chronic conditions that may interfere with the interpretation of the therapeutic effects or results: cardiovascular disease, kidney disease, diabetic neuropathy, dementia, epilepsy, etc.
- Patients who are taking steroids, immunosuppressants, mental illness drugs, or other drugs that may affect the results of the study
- If acupuncture is inadequate or unsafe: patients with hemorrhagic, receiving anticoagulants, severe diabetes and cardiovascular disease
- Patients who are pregnant or planning to become pregnant
- Patients with a serious mental illness
- Patients who are participated in clinical trials other than observational studies without therapeutic intervention.
- Patients who are difficult to complete the research participation agreement
- Other patients whose participation in the trial is judged by a researcher to be problematic
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Jaseng Hospital of Korean Medicine
Seoul, Gangnam-Gu, 135-896, South Korea
Jaseng Medical Foundation
Seoul, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
In-Hyuk Ha, PhD
Jaseng Medical Foundation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
October 1, 2019
First Posted
October 3, 2019
Study Start
July 3, 2019
Primary Completion
September 7, 2019
Study Completion
December 15, 2019
Last Updated
March 27, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share